Is Merck & Co. (MRK) a Good Long-Term Investment?

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here. Since 2015, for the first time, the market witnessed two consecutive quarterly losses. During the second quarter, the S&P 500 Index continued its decline, trading at -16.1%. Inflation concerns and interest rate hikes impacted the fund’s performance in the quarter. In addition, you can check the top 5 holdings of the fund to know its best picks in 2022.

Carillon Tower Advisers discussed stocks like Merck & Co., Inc. (NYSE:MRK) in the second quarter 2022 investor letter. Headquartered in Kenilworth, New Jersey, Merck & Co., Inc. (NYSE:MRK) is a healthcare company. On October 3, 2022, Merck & Co., Inc. (NYSE:MRK) stock closed at $87.55 per share. One-month return of Merck & Co., Inc. (NYSE:MRK) was 1.31% and its shares gained 7.29% of their value over the last 52 weeks. Merck & Co., Inc. (NYSE:MRK) has a market capitalization of $221.789 billion.

Here is what Carillon Tower Advisers specifically said about Merck & Co., Inc. (NYSE:MRK) in its Q2 2022 investor letter:

Merck & Co., Inc. (NYSE:MRK) reported a strong first quarter and raised its financial guidance for 2022. The company also continues to benefit from the recent rotation into pharmaceuticals, which historically has been a more defensive industry.”

Most Consumed Meats in the World in 2018 TZIDO SUN/

Merck & Co., Inc. (NYSE:MRK) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 79 hedge fund portfolios held Merck & Co., Inc. (NYSE:MRK) at the end of the second quarter which was 84 in the previous quarter.

We discussed Merck & Co., Inc. (NYSE:MRK) in another article and shared Chartwell Investment Partners’ views on the company. In addition, please check out our hedge fund investor letters Q2 2022 page for more investor letters from hedge funds and other leading investors.


Suggested Articles:

Disclosure: None. This article is originally published at Insider Monkey.

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire